Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Berger

Showing results (51-60 of 239) with videos related to

Pageof 24
Sort By:
The Journal of Invasive Cardiology|May 25, 2004
Alveolar hemorrhage associated with periprocedural eptifibatide administrationJames L Orford, Panayotis Fasseas, David R Holmes, et al.
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Distal protection devices during percutaneous coronary and carotid interventionsPanayotis Fasseas, James L Orford, Ali E Denktas, et al.
Urology|July 24, 2013
The effect of antiplatelet and anticoagulant therapy on the clinical outcome of patients undergoing ureteroscopyNicholas J Toepfer, Kelly Baylor, Yvette Henry, et al.
Journal of Thrombosis and Thrombolysis|November 2, 2007
Determining the efficacy of antiplatelet therapies for the individual: lessons from clinical trialsSteven R Steinhubl, David J Schneider, Peter B Berger, et al.
Journal of the American Heart Association|October 14, 2017
Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial FibrillationBrent A Williams, Michael A Evans, Ashley M Honushefsky, et al.
Journal of the American College of Cardiology|March 7, 2006
Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary interventionSteven R Steinhubl, Peter B Berger, Danielle M Brennan, et al.
American Heart Journal|May 8, 2004
Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplastyJassim Al Suwaidi, David R Holmes, Amar M Salam, et al.
American Heart Journal|June 17, 2004
Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularizationAbhiram Prasad, Ryan J Lennon, Charanjit S Rihal, et al.
Reviews in Cardiovascular Medicine|January 17, 2007
Therapeutic goals for effective platelet inhibition: a consensus documentStephen D Wiviott, Alan D Michelson, Peter B Berger, et al.
The Journal of Invasive Cardiology|July 11, 2007
Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trialSorin J Brener, Steven R Steinhubl, Peter B Berger, et al.
Pageof 24

Showing results (51-60 of 239) with videos related to

Sort By:
Pageof 24
The Journal of Invasive Cardiology|May 25, 2004
Alveolar hemorrhage associated with periprocedural eptifibatide administrationJames L Orford, Panayotis Fasseas, David R Holmes, et al.
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Distal protection devices during percutaneous coronary and carotid interventionsPanayotis Fasseas, James L Orford, Ali E Denktas, et al.
Urology|July 24, 2013
The effect of antiplatelet and anticoagulant therapy on the clinical outcome of patients undergoing ureteroscopyNicholas J Toepfer, Kelly Baylor, Yvette Henry, et al.
Journal of Thrombosis and Thrombolysis|November 2, 2007
Determining the efficacy of antiplatelet therapies for the individual: lessons from clinical trialsSteven R Steinhubl, David J Schneider, Peter B Berger, et al.
Journal of the American Heart Association|October 14, 2017
Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial FibrillationBrent A Williams, Michael A Evans, Ashley M Honushefsky, et al.
Journal of the American College of Cardiology|March 7, 2006
Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary interventionSteven R Steinhubl, Peter B Berger, Danielle M Brennan, et al.
American Heart Journal|May 8, 2004
Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplastyJassim Al Suwaidi, David R Holmes, Amar M Salam, et al.
American Heart Journal|June 17, 2004
Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularizationAbhiram Prasad, Ryan J Lennon, Charanjit S Rihal, et al.
Reviews in Cardiovascular Medicine|January 17, 2007
Therapeutic goals for effective platelet inhibition: a consensus documentStephen D Wiviott, Alan D Michelson, Peter B Berger, et al.
The Journal of Invasive Cardiology|July 11, 2007
Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trialSorin J Brener, Steven R Steinhubl, Peter B Berger, et al.
Pageof 24